Outcomes Using MARS for Patients With ALF

Description

Retrospective chart review will be conducted on patients at Methodist Dallas Medical Center, meeting the inclusion criteria from January 1, 2019 to December 15, 2020 to determine the transplant free survival and overall survival and other secondary outcome measures.

Conditions

Alcoholic Hepatitis, Acute Liver Failure

Study Overview

Study Details

Study overview

Retrospective chart review will be conducted on patients at Methodist Dallas Medical Center, meeting the inclusion criteria from January 1, 2019 to December 15, 2020 to determine the transplant free survival and overall survival and other secondary outcome measures.

Outcomes Using MARS: A Single Center Experience

Outcomes Using MARS for Patients With ALF

Condition
Alcoholic Hepatitis
Intervention / Treatment

-

Contacts and Locations

Dallas

Methodist Dallas Medical Center, Dallas, Texas, United States, 75203

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Patient not meeting the inclusion criteria will be excluded.

Ages Eligible for Study

to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Methodist Health System,

Parvez Mantry, MD, PRINCIPAL_INVESTIGATOR, Methodist

Study Record Dates

2024-12-31